Literature DB >> 7627637

Adenovirus-mediated gene transfer into striated muscles.

G Acsadi1, B Massie, A Jani.   

Abstract

Mesh：

Year:  1995        PMID： 7627637     DOI： 10.1007/bf00188137

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  158 in total

Review 1.  Progress toward human gene therapy.

Authors:  T Friedmann
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

2.  Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.

Authors:  J Dhawan; L C Pan; G K Pavlath; M A Travis; A M Lanctot; H M Blau
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

3.  Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport.

Authors:  L E Babiss; H S Ginsberg; J E Darnell
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

4.  Adenoviral vectors as functional retrograde neuronal tracers.

Authors:  V Ridoux; J J Robert; X Zhang; M Perricaudet; J Mallet; G Le Gal La Salle
Journal:  Brain Res       Date:  1994-06-13       Impact factor: 3.252

5.  High level expression in 293 cells of the herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector.

Authors:  N Lamarche; B Massie; M Richer; H Paradis; Y Langelier
Journal:  J Gen Virol       Date:  1990-08       Impact factor: 3.891

6.  Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.

Authors:  T Ragot; N Vincent; P Chafey; E Vigne; H Gilgenkrantz; D Couton; J Cartaud; P Briand; J C Kaplan; M Perricaudet
Journal:  Nature       Date:  1993-02-18       Impact factor: 49.962

7.  Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells.

Authors:  A Garnier; J Côté; I Nadeau; A Kamen; B Massie
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

Review 8.  The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.

Authors:  G Karpati; G Acsadi
Journal:  Muscle Nerve       Date:  1993-11       Impact factor: 3.217

9.  Adenovirus-mediated augmentation of cell transfection with unmodified plasmid vectors.

Authors:  K Yoshimura; M A Rosenfeld; P Seth; R G Crystal
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

10.  Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron.

Authors:  B B Mason; A R Davis; B M Bhat; M Chengalvala; M D Lubeck; G Zandle; B Kostek; S Cholodofsky; S Dheer; K Molnar-Kimber
Journal:  Virology       Date:  1990-08       Impact factor: 3.616
View more
  6 in total

1.  Therapeutic strategies for the inherited neuropathies.

Authors:  Michael E Shy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

2.  New adenovirus vectors for protein production and gene transfer.

Authors:  B Massie; D D Mosser; M Koutroumanis; I Vitté-Mony; L Lamoureux; F Couture; L Paquet; C Guilbault; J Dionne; D Chahla; P Jolicoeur; Y Langelier
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

3.  Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette.

Authors:  B Massie; F Couture; L Lamoureux; D D Mosser; C Guilbault; P Jolicoeur; F Bélanger; Y Langelier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.

Authors:  H G Zhang; G Bilbao; T Zhou; J L Contreras; J Gómez-Navarro; M Feng; I Saito; J D Mountz; D T Curiel
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Characterization of adenovirus hexons by their epitope composition.

Authors:  E Adám; I Nász; A Lengyel
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Strategy for treating motor neuron diseases using a fusion protein of botulinum toxin binding domain and streptavidin for viral vector access: work in progress.

Authors:  Daniel B Drachman; Robert N Adams; Uma Balasubramanian; Yang Lu
Journal:  Toxins (Basel)       Date:  2010-12-20       Impact factor: 4.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.